A systemic immunogenic reactor leveraging modified γ-cyclodextrins for photo-controlled cancer Ca(2+) interference via modulating MICU1

一种利用修饰的γ-环糊精进行光控癌症Ca(2+)干扰的系统性免疫原性反应器,通过调节MICU1实现。

阅读:1

Abstract

Interference with calcium homeostasis provokes tumor cell death and immune response, providing a novel direction for tumor immunotherapy as a promising cancer treatment strategy. Nevertheless, most reported Ca(2+)-overloaded nanoinducers encounter challenges such as intricate preparation procedures, safety concerns arising from inorganic material input, and limited anti-tumor efficiency. Herein, we synthesized a biocompatible and pH-sensitive Ca-doped cyclodextrin metal-organic framework (Ca/K-MOF) as a carrier, which was then loaded with photosensitizer hypericin (HY) via a simple one-pot synthesis to form HY@Ca/K-MOF. To enhance the stability both in vitro and in vivo, we coated HY@Ca/K-MOF with a hydrophilic layer of PEG ((PEG)HY@Ca/K-MOF). When exposed to 590 nm photoirradiation, (PEG)HY@Ca/K-MOF, with its pH-responsive dissociation, the Ca(2+) and HY mediators released at the tumor site share the responsibility of triggering intracellular Ca(2+) disturbances, which amplified the production of reactive oxygen species (ROS) and led to mitochondrial calcium overload through modulating mitochondrial MICU1 function. Under photocontrol, this interplay between ROS generation and mitochondrial calcium overload created a bidirectional amplification effect, where each process reinforced the other, subsequently eliciting a pyroptosis-evoked immune response. Significantly, this newly constructed delivery platform effectively suppressed both primary and distant tumors without the need for additional immunological interventions. In summary, this Ca(2+)-doped MOF-based nanomaterial provides a promising approach for efficient tumor photo-controlled mitochondrial Ca(2+) overload-pyroptosis immunotherapy.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。